#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15454	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2008	761.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1416	1416	C	897	C	840	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	15454	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2008	761.4	0	HET	.	.	.	C207T	.	207	207	C	439	439	C	805	C,T	429,311	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27588	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3502	784.0	0	.	n	.	0	T695C	SNP	695	695	T	1054	1054	C	835	C	783	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27588	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3502	784.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2330	2330	C	870	C,G	806,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27588	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3502	784.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2404	2404	A	831	A	792	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	27588	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3502	784.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2956	2956	C	850	C	802	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2082	folP	855	855	100.0	folP.l15.c4.ctg.1	1447	142.8	1	SNP	p	R229S	1	.	.	685	687	AGC	999	1001	AGC	220;221;221	A;G;C,T	208;209;205,1	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4932	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3457	142.2	1	SNP	p	S91F	1	.	.	271	273	TTC	643	645	TTC	148;148;148	T;T;C	137;138;137	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4932	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3457	142.2	1	SNP	p	D95G	1	.	.	283	285	GGC	655	657	GGC	148;149;148	G;G;C	137;138;138	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	4932	gyrA	2751	2751	99.85	gyrA.l6.c30.ctg.1	3457	142.2	1	SNP	p	G95N	0	.	.	283	285	GGC	655	657	GGC	148;149;148	G;G;C	137;138;138	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	1664	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1452	114.2	1	SNP	p	G45D	0	.	.	133	135	GGC	521	523	GGC	173;174;174	G;G;C	159;160;158	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	780	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1037	74.8	0	.	n	.	0	A197.	DEL	197	197	A	542	542	A	191	A	178	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4994	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2834	175.2	1	SNP	p	D86N	0	.	.	256	258	GAC	527	529	GAC	192;190;191	G,T;A;C,A	184,1;174;179,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4994	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2834	175.2	1	SNP	p	R87I	0	.	.	259	261	CGT	530	532	CGT	191;193;189	C;G;T	182;184;181	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4994	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2834	175.2	1	SNP	p	R87W	0	.	.	259	261	CGT	530	532	CGT	191;193;189	C;G;T	182;184;181	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4994	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2834	175.2	1	SNP	p	S87R	1	.	.	259	261	CGT	530	532	CGT	191;193;189	C;G;T	182;184;181	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4994	parC	2304	2304	100.0	parC.l6.c4.ctg.1	2834	175.2	1	SNP	p	S88P	0	.	.	262	264	TCC	533	535	TCC	190;186;185	T;C;C	182;179;179	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4242	parE	1986	1986	100.0	parE.l6.c4.ctg.1	2879	146.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1668	1670	GGC	206;203;200	G;G;C	188;185;181	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4158	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2189	188.2	1	SNP	p	A311V	0	.	.	931	933	GCC	1129	1131	GCC	252;255;260	G;C;C	231;235;239	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4158	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2189	188.2	1	SNP	p	I312M	1	.	.	934	936	ATG	1132	1134	ATG	259;257;257	A;T;G	239;238;236	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4158	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2189	188.2	1	SNP	p	V316T	1	.	.	946	948	ACC	1144	1146	ACC	254;253;253	A;C;C	235;235;234	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4158	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2189	188.2	1	SNP	p	T316P	0	.	.	946	948	ACC	1144	1146	ACC	254;253;253	A;C;C	235;235;234	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4158	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2189	188.2	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1645	1647	ACC	222;224;227	A,G;C;C	202,1;210;218	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4158	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2189	188.2	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1699	1701	GCG	214;217;217	G;C;G	200;200;200	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4158	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2189	188.2	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1699	1701	GCG	214;217;217	G;C;G	200;200;200	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4158	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2189	188.2	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1822	1824	GGT	176;178;179	G;G;T	163;165;164	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4158	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2189	188.2	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1831	1833	AGC	181;178;178	A;G;C	167;163;163	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4158	penA	1746	1746	100.0	penA.l15.c30.ctg.1	2189	188.2	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1849	1851	CCG	156;161;157	C,G;C,G;G	117,7;123,1;123	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5804	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3161	183.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1677	1679	CCG	195;197;200	C,T;C;G	170,2;178;170	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2356	porA	1146	1146	99.91	porA.l6.c30.ctg.1	1908	122.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	570	570	C	148	C	139	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3204	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1616	197.3	0	.	p	.	0	I45V	NONSYN	133	135	ATT	439	441	GTT	259;259;256	G;T;T	242;239;237	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3204	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1616	197.3	0	.	p	.	0	K249_L250insSK	INS	745	745	A	1051	1051	A	259	A	244	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3204	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1616	197.3	1	SNP	p	G120K	1	.	.	358	360	AAG	664	666	AAG	243;242;245	A;A;G	226;228;225	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3204	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1616	197.3	1	SNP	p	N121D	0	.	.	361	363	AAC	667	669	AAC	243;242;242	A;A;C	228;227;227	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	3204	porB1b	1038	1038	99.33	porB1b.l6.c4.ctg.1	1616	197.3	1	SNP	p	A121N	1	.	.	361	363	AAC	667	669	AAC	243;242;242	A;A;C	228;227;227	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	11462	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4792	238.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1340	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1108	120.3	1	SNP	p	V57M	1	.	.	169	171	ATG	533	535	ATG	316;317;315	A;T;G	287;286;284	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
